Progressive and anti-abortion? New group plays fast and loose to make points

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

Cri­net­ics Phar­ma­ceu­ti­cals shared Phase 2 da­ta in­ves­ti­gat­ing atumel­nant in pa­tients with con­gen­i­tal adren­al hy­per­pla­sia that showed the drug re­duced bio­mark­ers of the dis­ease. The da­ta,